Technical Analysis for GSK - GlaxoSmithKline PLC

Grade Last Price % Change Price Change
grade D 39.46 0.31% 0.12
GSK closed up 0.31 percent on Friday, May 17, 2019, on 81 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical GSK trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup 0.31%
Stochastic Buy Signal Bullish 0.31%
Oversold Stochastic Weakness 0.31%
Oversold Stochastic Weakness -0.30%
Cup with Handle Other 0.64%
Lower Bollinger Band Walk Weakness 0.64%
Down 3 Days in a Row Weakness 0.64%
Down 4 Days in a Row Weakness 0.64%

Older signals for GSK ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also produces paediatric and adult vaccines to prevent a range of infectious diseases, including hepatitis A and B; diphtheria, tetanus, and whooping cough; measles, mumps, and rubella; polio; typhoid; influenza; and bacterial meningitis. In addition, it provides consumer health products in oral care, nutritional, total wellness, and skin health areas. The company's total wellness products include Panadol for the treatment of paracetamol-based treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; ENO Tums, a rapid relief antacid; and oral care products comprise Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to improve comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. Its nutrition products include Lucozade for energy and hydration; and Horlicks and Maxinutrition for nutrition; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Energy Medicine Health Cancer Pharmaceutical Drugs Infectious Diseases Medication Pharmaceutical Products Rare Diseases Influenza Asthma HIV Nutrition Products Antibiotic Depression Infections Wellness Products Oral Care Products Fever Smoking Cessation Eczema Glaxosmithkline Consumer Health Products Hepatitis A Joint Pain Measles Mumps Nicotine Rubella Tetanus
Is GSK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 17 Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site
May 17 GSK and Novartis liniment marketing misled Australian consumers - court
May 16 How to Invest in Biotech: Known Your Catalysts
May 16 Thermo Fisher to acquire manufacturing site in Ireland
May 16 GSK expands collaboration with Zymeworks
May 16 Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK
May 15 ViiV Healthcare to evaluate Matinas Bio's LNC platform
May 15 Matinas BioPharma Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates
May 14 Stanford Dad Accused of $6.5 Million Payment in College Scandal Has a New Problem
May 13 FDA finalizes guidance on interchangeable biosimilars
See more GSK news...
Indicators
Indicator Value
52 Week High 42.36
52 Week Low 36.41
Average Volume 2,386,607
200-Day Moving Average 39.9726
50-Day Moving Average 40.5869
20-Day Moving Average 39.9815
10-Day Moving Average 39.598
Average True Range 0.4638
ADX 24.76
+DI 16.3024
-DI 28.2797
Chandelier Exit (Long, 3 ATRs ) 39.7686
Chandelier Exit (Short, 3 ATRs ) 40.4614
Upper Bollinger Band 41.0394
Lower Bollinger Band 38.9236
Percent B (%b) 0.25
BandWidth 5.291948
MACD Line -0.3547
MACD Signal Line -0.2957
MACD Histogram -0.0589
Fundamentals Value
Market Cap 96.44 Billion
Num Shares 2.44 Billion
EPS 1.03
Price-to-Earnings (P/E) Ratio 38.31
Price-to-Sales 2.27
Price-to-Book 83.56
PEG Ratio 1.10
Dividend 1.99
Dividend Yield 5.04%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.08
Resistance 3 (R3) 40.08 39.88 39.97
Resistance 2 (R2) 39.88 39.72 39.88 39.94
Resistance 1 (R1) 39.67 39.63 39.78 39.67 39.90
Pivot Point 39.47 39.47 39.52 39.47 39.47
Support 1 (S1) 39.26 39.31 39.37 39.26 39.02
Support 2 (S2) 39.06 39.22 39.06 38.98
Support 3 (S3) 38.85 39.06 38.95
Support 4 (S4) 38.85